Country, language and currency
- Social bookmarks:
- Testimonials
-
Read more »
Our billing is certified by:
-
- Par Pharmaceutical Companies Reports First Quarter 2012 Results - MarketWatch (press release)
- Updated NewsPar Pharmaceutical Companies Reports First Quarter 2012 ResultsMarketWatch (press release)Metoprolol: For the quarter ended March 31, 2012, net sales of metoprolol succinate were $61
- Sun Pharma rating upped to overweight, target Rs. 670 - Financial Express
- Sun Pharma rating upped to overweight, target Rs
- Shoot Better Than Par With This Cheap Drug Stock - Forbes
- Shoot Better Than Par With This Cheap Drug StockForbesSales of its biggest product, Metoprolol, which is the authorized generic for all strengths of AstraZeneca's Toprol XL, rose 9
- Contrary to popular belief, beta-blockers don't prevent colorectal cancer - Los Angeles Times
- Zee NewsContrary to popular belief, beta-blockers don't prevent colorectal cancerLos Angeles TimesAmong the best known are atenolol (Tenormin), bisoprolol (Zebeta), metoprolol (Lopresor or Toprol) and carvedilol (Coreg)
- BP Meds No Help Against Colorectal Cancer - MedPage Today
- BP Meds No Help Against Colorectal CancerMedPage TodayPrevious prescription drug database studies had also associated use of these drugs (which include metoprolol and atenolol) with a reduced risk of prostate, bladder, and all cancers combined
